Cargando…

A new model for identification of HBV-related pre-ACLF

Detalles Bibliográficos
Autores principales:	Jalan, Rajiv, Sundaram, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472060/ https://www.ncbi.nlm.nih.gov/pubmed/36119720 http://dx.doi.org/10.1016/j.jhepr.2022.100554

Ejemplares similares

A Modified MELD Model for Chinese Pre-ACLF and ACLF Patients and It Reveals Poor Prognosis in Pre-ACLF Patients
por: Xia, Qi, et al.
Publicado: (2013)

Identification of a Potential miRNA–mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Connection between HPS and ACLF: a solution of chaos?
por: Maruyama, Hitoshi, et al.
Publicado: (2021)

Corrigendum: Identification of a Potential miRNA-mRNA Regulatory Network Associated With the Prognosis of HBV-ACLF
por: Ma, Shanshan, et al.
Publicado: (2021)

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
por: Liu, Fangfang, et al.
Publicado: (2020)

Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF
por: Wu, Zhe-Bin, et al.
Publicado: (2021)

Mean arterial pressure drop is an independent risk factor of hepatorenal syndrome in patients with HBV-ACLF
por: Zheng, Xingrong, et al.
Publicado: (2022)

Validation of CLIF-C ACLF score to define a threshold for futility of intensive care support for patients with acute-on-chronic liver failure
por: Engelmann, Cornelius, et al.
Publicado: (2018)

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients
por: Zhang, Xueyun, et al.
Publicado: (2022)

Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
por: Weiss, Emmanuel, et al.
Publicado: (2021)

Prognostic Value of Acute-On-Chronic Liver Failure (ACLF) Score in Critically Ill Patients with Cirrhosis and ACLF
por: Lin, Xinran, et al.
Publicado: (2020)

Serum Lactate Level Predicts Short-Term and Long-Term Mortality of HBV-ACLF Patients: A Prospective Study
por: Nie, Yuan, et al.
Publicado: (2020)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
por: Seeßle, Jessica, et al.
Publicado: (2020)

Comparing CLIF-C ACLF, CLIF-C ACLF(lactate), and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
por: Kuo, Chao-Cheng, et al.
Publicado: (2021)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF
por: Huang, Yandi, et al.
Publicado: (2022)

Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs
por: Liang, Jiajun, et al.
Publicado: (2022)

Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF
por: Li, Ning, et al.
Publicado: (2017)

Resolvin D1 promotes the resolution of inflammation in the ACLF rat model by increasing the proportion of Treg cells
por: Chen, Linjun, et al.
Publicado: (2023)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF
por: Blasi, Annabel, et al.
Publicado: (2019)

Clinical Validation of Global Coagulation Tests to Guide Blood Component Transfusions in Cirrhosis and ACLF
por: Premkumar, Madhumita, et al.
Publicado: (2021)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Knockdown of CXCL1 improves ACLF by reducing neutrophil recruitment to attenuate ROS production and hepatocyte apoptosis
por: Tang, Shima, et al.
Publicado: (2023)

Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
por: Teriaky, Anouar, et al.
Publicado: (2013)

Special Issue: “Updates on HBV Infection”
por: Chemin, Isabelle, et al.
Publicado: (2022)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model
por: Zhang, Suyanpeng, et al.
Publicado: (2021)

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
por: Tong, Jingjing, et al.
Publicado: (2022)

Respiratory syncytial virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: Treated with ribavirin and IVIg
por: Kapoor, Sorabh, et al.
Publicado: (2022)

A new beginning: New horizons
por: Natarajan, Sundaram
Publicado: (2017)

Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?
por: Einollahi, Behzad
Publicado: (2012)

Is PD-1 blockade a potential therapy for HBV?
por: Féray, Cyrille, et al.
Publicado: (2019)

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
por: Görgülü, Esra, et al.
Publicado: (2022)

Galectin-3 critically mediates the hepatoprotection conferred by M2-like macrophages in ACLF by inhibiting pyroptosis but not necroptosis signalling
por: Bai, Li, et al.
Publicado: (2022)

Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure
por: Ramzan, Moazma, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7i0jaiehvofjh6dq1l46ql6893